Molecular mechanisms of FIV infection

Veterinary Immunology and Immunopathology

Volumn 123, Issue 1-2, 2008, Pages 3-13

  Elder, John H ^a   Sundstrom, Magnus ^a   de Rozieres, Sohela ^b   de Parseval, Aymeric ^c   Grant, Chris K ^d   Lin, Ying Chuan ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Biomatrica   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d Custom Monoclonals International   (United States)

Author keywords

CD134; CXCR4; Feline immunodeficiency virus; Receptor

Indexed keywords

GAG PROTEIN; POLYPROTEIN; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

DRUG BIOAVAILABILITY; FELINE IMMUNODEFICIENCY VIRUS; GENE STRUCTURE; GENOME SIZE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIFE CYCLE; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN STRUCTURE; REVIEW; UNSPECIFIED SIDE EFFECT;

AMINO ACID SEQUENCE; ANIMALS; CATS; DISEASE MODELS, ANIMAL; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENOME, VIRAL; IMMUNODEFICIENCY VIRUS, FELINE; VIRUS REPLICATION;

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; LENTIVIRUS;

EID: 43049182988     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.01.007     Document Type: Review

References (125)

1. Bach J.M., Hurtrel M., Chakrabarti L., Ganiere J.P., Montagnier L., and Hurtrel B. Early stages of feline immunodeficiency virus infection in lymph nodes and spleen. AIDS Res. Hum. Retroviruses 10 (1994) 1731-1738
2. Bachmann M.H., Mathiason-Dubard C., Learn G.H., Rodrigo A.G., Sodora D.L., Mazzetti P., Hoover E.A., and Mullins J.I. Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J. Virol. 71 (1997) 4241-4253
3. Beebe A.M., Dua N., Faith T.G., Moore P.F., Pedersen N.C., and Dandekar S. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J. Virol. 68 (1994) 3080-3091
4. Bouhamdan M., Benichou S., Rey F., Navarro J.M., Agostini I., Spire B., Camonis J., Slupphaug G., Vigne R., Benarous R., and Spire J. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70 (1996) 697-704
5. + T lymphocytes. J. Virol. 65 (1991) 3359-3364
6. Brunner D., and Pedersen N.C. Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J. Virol. 63 (1989) 5483-5488
7. Callanan J.J., Racz P., Thompson H., and Jarrett O. Morphologic Characterization of the Lymph Node Changes in Feline Immunodeficiency Virus Infection as an Animal Model of AIDS (1993), S. Karger, Basel, Switzerland
8. Chatterji U., de Parseval A., and Elder J.H. Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators. J. Virol. 76 (2002) 9624-9634
9. Cohen O.J., and Fauci A.S. N. Engl. J. Med. 339 5 (1998) 341-343
10. Collier A.C., Coombs R.W., Schoenfeld D.A., Bassett R.L., Timpone J., Baruch A., Jones M., Facey K., Whitacre C., McAuliffe V.J., Friedman H.M., Merigan T.C., Reichman R.C., Hooper C., and Corey L. N. Engl. J. Med. 334 16 (1996) 1011-1017
11. Condra J.H., Schleif W.A., Blahy O.M., Gabryelski L.J., Graham D.J., Quintero J.C., Rhodes A., Robbins H.L., Roth E., and Shivaprakash M. Nature 374 6522 (1995) 569-571
12. de Parseval A., and Elder J.H. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J. Virol. 73 (1999) 608
13. de Parseval A., and Elder J.H. Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75 (2001) 4528-4539
14. + T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13044-13049
15. de Parseval A., Bobardt M.D., Elder J.H., David G., and Zolla-Pazner S. A highly conserved arginine in Gp120 governs HIV-1 binding to both CCR5 and syndecans via a sulfated motif. J. Biol. Chem. 280 (2005) 39493-39504
16. de Parseval A., Chatterji U., Morris G., Sun P., and Olson A.J. Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat. Struct. Mol. Biol. 12 (2005) 60-66
17. de Parseval A., Grant C.K., Sastry K.J., and Elder J.H. Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J. Virol. 80 (2006) 3088-3091
18. Delwart E.L., and Gordon C.J. Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis. Methods 12 (1997) 348-354
19. Demirov D.G., Orenstein J.M., and Freed E.O. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J. Virol. 76 (2002) 105-117
20. Dunn B.M., Gustchina A., Wlodawer A., and Kay J. Methods Enzymol. 241 (1994) 254-278
21. Dunn B.M., Pennington M.W., Frase D.C., and Nash K. Biopolymers 51 1 (1999) 69-77
22. Elder J.H., Lerner D.L., Hasselkus-Light C.S., Fontenot D.J., and Hunter E. Distinct subsets of retroviruses encode dUTPase. J. Virol. 66 (1992) 1791-1794
23. Elder J.H., Schnolzer M., Hasselkus-Light C.S., Henson M., Lerner D.A., Phillips T.R., Wagaman P.C., and Kent S.B. Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. J. Virol. 67 (1993) 1869-1876
24. English R.V., Nelson P., Johnson C.M., Nasisse M., and Tompkins W.A. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. Infect. Dis. 170 (1994) 543-552
25. Erickson J., Neidhart D.J., VanDrie J., Kempf D.J., Wang X.C., Norbeck D.W., Plattner J.J., Rittenhouse J.W., Turon M., and Wideburg N. Science 249 4968 (1990) 527-533
26. Freed E.O. Viral late domains. J. Virol. 76 (2002) 4679-4687
27. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., and Zavitz K.H. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107 (2001) 55-65
28. Gemeniano M.C., Sawai E.T., Leutenegger C.M., and Sparger E.E. Feline immunodeficiency virus ORF-A is required for virus particle formation and virus infectivity. J. Virol. 77 (2003) 8819-8830
29. Gemeniano M.C., Sawai E.T., and Sparger E.E. Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest. Virology 325 (2004) 167-174
30. Gross I., Hohenberg H., Wilk T., Wiegers K., Grattinger M., Muller B., Fuller S., and Krausslich H.G. EMBO J. 19 1 (2000) 103-113
31. Gulick R.M., Mellors J.W., Havlir D., Eron J.J., Gonzalez C., McMahon D., Richman D.D., Valentine F.T., Jonas L., Meibohm A., Emini E.A., and Chodakewitz J.A. N. Engl. J. Med. 337 11 (1997) 734-739
32. Hurtrel B., Chakrabarti L., Hurtrel M., Bach J.M., and Ganiere J.P. Early events in lymph nodes during infection with SIV and FIV. Res. Virol. 145 (1994) 221-227
33. Jacobsen H., Hanggi M., Ott M., Duncan I.B., Owen S., Andreoni M., Vella S., and Mous J. J. Infect. Dis. 173 6 (1996) 1379-1387
34. Johnson V.A., Brun-Vezinet F., Clotet B., Conway B., Kuritzkes D.R., Pillay D., Schapiro J.M., Telenti A., and Richman D.D. Top. HIV Med. 13 4 (2005) 125-131
35. + T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors. J. Virol. 79 (2005) 4965-4976
36. Katz R.A., and Skalka A.M. Annu. Rev. Biochem. 63 (1994) 133-173
37. Kirk O., Katzenstein T.L., Gerstoft J., Mathiesen L., Nielsen H., Pedersen C., and Lundgren J.D. AIDS 13 1 (1999) F9-F16
38. Kozal M. AIDS Patient Care STDS 18 4 (2004) 199-208
39. Kutilek V.D., Sheeter D.A., Elder J.H., and Torbett B.E. Curr. Drug Targets Infect. Disord. 3 4 (2003) 295-309
40. Kwong P.D., Doyle M.L., Casper D.J., Cicala C., and Leavitt S.A. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420 (2002) 678-682
41. Labrijn A.F., Poignard P., Raja A., Zwick M.B., and Delgado K. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J. Virol. 77 (2003) 10557-10565
42. Laco G.S., Fitzgerald M.C., Morris G.M., Olson A.J., Kent S.B., and Elder J.H. J. Virol. 71 7 (1997) 5505-5511
43. Laco G.S., Schalk-Hihi C., Lubkowski J., Morris G., and Zdanov A. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor. Biochemistry 36 (1997) 10696-10708
44. Lafrado L., Podell M., Krakowka S., Hayes K., Hanlon M., Hanlon M., and Mathes L.E. FIV: a model for retrovirus-induced pathogenesis. AIDS Res. Rev. 3 (1993) 115-150
45. Lawrence J., Schapiro J., Winters M., Montoya J., Zolopa A., Pesano R., Efron B., Winslow D., and Merigan T.C. J. Infect. Dis. 179 6 (1999) 1356-1364
46. Lee T., Laco G.S., Torbett B.E., Fox H.S., and Lerner D.L. Analysis of the S3 and S3′ subsite specificities of feline immunodeficiency virus (FIV) protease: Development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 939-944
47. Lee T., Le V.D., Lim D., Lin Y.C., Morris G., Wong A.L., Olson A.J., Elder J.H., and Wong C.H. J. Am. Chem. Soc. 121 (1999) 1145-1155
48. Lerner D.L., Wagaman P.C., Phillips T.R., Prospero-Garcia O., and Henriksen S.J. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7480-7484
49. Lin Y.C., Beck Z., Lee T., Le V.D., Morris G.M., Olson A.J., Wong C.H., and Elder J.H. Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease. J. Virol. 74 10 (2000) 4710-4720
50. Lin Y.C., Beck Z., Morris G.M., Olson A.J., and Elder J.H. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases. J. Virol. 77 12 (2003) 6589-6600
51. Lin Y.C., Brik A., de Parseval A., Tam K., Torbett B.E., Wong C.H., and Elder J.H. Altered Gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system. J. Virol. 80 16 (2006) 7832-7843
52. Lusso P., Earl P.L., Sironi F., Santoro F., and Ripamonti C. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains. J. Virol. 79 (2005) 6957-6968
53. Mangeat B., Turelli P., Caron G., Friedli M., and Perrin L. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 (2003) 99-103
54. Manrique M.L., Rauddi M.L., Gonzalez S.A., and Affranchino J.L. Functional domains in the feline immunodeficiency virus nucleocapsid protein. Virology 327 (2004) 83-92
55. Mansky L.M., Preveral S., Selig L., Benarous R., and Benichou S. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J. Virol. 74 (2000) 7039-7047
56. Martin-Serrano J., Zang T., and Bieniasz P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7 (2001) 1313-1319
57. Miller M., Schneider J., Sathyanarayana B.K., Toth M.V., Marshall G.R., Clawson L., Selk L., Kent S.B., and Wlodawer A. Science 246 4934 (1989) 1149-1152
58. Molla A., Korneyeva M., Gao Q., Vasavanonda S., Schipper P.J., Mo H.M., Markowitz M., Chernyavskiy T., Niu P., Lyons N., Hsu A., Granneman G.R., Ho D.D., Boucher C.A., Leonard J.M., Norbeck D.W., and Kempf D.J. Nat. Med. 2 7 (1996) 760-766
59. Moore M.L., Bryan W.M., Fakhoury S.A., Magaard V.W., Huffman W.F., Dayton B.D., Meek T.D., Hyland L., Dreyer G.B., and Metcalf B.W. Biochem. Biophys. Res. Commun. 159 2 (1989) 420-425
60. Morikawa S., and Bishop D.H. Identification and analysis of the gag-pol ribosomal frameshift site of feline immunodeficiency virus. Virology 186 (1992) 389-397
61. Moulard M., Phogat S.K., Shu Y., Labrijn A.F., and Xiao X. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6913-6918
62. North T.W., North G.L., and Pedersen N.C. Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome. Antimicrob. Agents Chemother. 33 (1989) 915-919
63. Novotney C., English R.V., Housman J., Davidson M.G., and Nasisse M.P. Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus. AIDS 4 (1990) 1213-1218
64. Obert L.A., and Hoover E.A. Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res. Hum. Retroviruses 16 (2000) 677-688
65. Olmsted R.A., Barnes A.K., Yamamoto J.K., Hirsch V.M., and Purcell R.H. Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 2448-2452
66. O'Neil L.L., Burkhard M.J., Diehl L.J., and Hoover E.A. Vertical transmission of feline immunodeficiency virus. Semin. Vet. Med. Surg. (Small Anim.) 10 (1995) 266-278
67. O'Neil L.L., Burkhard M.J., and Hoover E.A. Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J. Virol. 70 (1996) 2894-2901
68. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., and Holmberg S.D. N. Engl. J. Med. 338 13 (1998) 853-860
69. Pancino G., Fossati I., Chappey C., Castelot S., and Hurtrel B. Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 192 (1993) 659-662
70. Parodi A.L., Femenia F., Moraillon A., Crespeau F., and Fontaine J.J. Histopathological changes in lymph nodes of cats experimentally infected with the feline immunodeficiency virus (FIV). J. Comp. Pathol. 111 (1994) 165-174
71. Pedersen N.C. The Feline immunodeficiency virus. In: Levy J.A. (Ed). The Retroviridae (1993), Plenum Press, NewYork 181-228
72. Pedersen N.C., Ho E.W., Brown M.L., and Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235 (1987) 790-793
73. Pettit S.C., Simsic J., Loeb D.D., Everitt L., Hutchison C.A.d., and Swanstrom R. J. Biol. Chem. 266 22 (1991) 14539-14547
74. Pettit S.C., Moody M.D., Wehbie R.S., Kaplan A.H., Nantermet P.V., Klein C.A., and Swanstrom R. J. Virol. 68 12 (1994) 8017-8027
75. Pettit S.C., Sheng N., Tritch R., Erickson-Viitanen S., and Swanstrom R. Adv. Exp. Med. Biol. 436 (1998) 15-25
76. Pettit S.C., Everitt L.E., Choudhury S., Dunn B.M., and Kaplan A.H. J. Virol. 78 16 (2004) 8477-8485
77. Pettit S.C., Clemente J.C., Jeung J.A., Dunn B.M., and Kaplan A.H. J. Virol. 79 16 (2005) 10601-10607
78. Pettit S.C., Lindquist J.N., Kaplan A.H., and Swanstrom R. Retrovirology 2 1 (2005) 66
79. Phillips T.R., Talbott R.L., Lamont C., Muir S., and Lovelace K. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64 (1990) 4605-4613
80. Phillips T.R., Lamont C., Konings D.A., Shacklett B.L., and Hamson C.A. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66 (1992) 5464-5471
81. Phillips T.R., Prospero-Garcia O., Puaoi D.L., Lerner D.L., and Fox H.S. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 75 (1994) 979-987
82. Phillips T.R., Prospero-Garcia O., Wheeler D.W., Wagaman P.C., and Lerner D.L. Neurologic dysfunctions caused by a molecular clone of feline immundeficiency virus, FIV-PPR. J. Neurovirol. 2 (1996) 388-396
83. Poeschla E.M., and Looney D.J. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J. Virol. 72 (1998) 6858-6866
84. Polgar L., Szeltner Z., and Boros I. Biochemistry 33 31 (1994) 9351-9357
85. Prospero-Garcia O., Herold N., Phillips T.R., Elder J.H., and Bloom F.E. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc. Nat. Acad. Sci. U.S.A. 91 (1994) 12947-12951
86. Prospero-Garcia O., Herold N., Waters A.K., Phillips T.R., and Elder J.H. Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res. 659 (1994) 254-258
87. Rhee S.Y., Gonzales M.J., Kantor R., Betts B.J., Ravela J., and Shafer R.W. Human immunodeficiency virus reverse transcripts and protease sequence database. Nucleic Acids Res. 31 1 (2003) 298-303
88. Richman D.D., Morton S.C., Wrin T., Hellmann N., Berry S., Shapiro M.F., and Bozzette S.A. AIDS 18 10 (2004) 1393-1401
89. Rideout B.A., Lowensteine L.J., Hutson C.A., Moore P.F., and Pedersen N.C. Characterization of morphologic changes and lymphocyte subset distribution in lymph nodes from cats with naturally acquired feline immunodeficiency virus infection. Vet. Pathol. 29 (1992) 391-399
90. Rogers A.B., and Hoover E.A. Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms. J. Infect. Dis. 178 (1998) 960-967
91. Schnolzer M., Rackwitz H.R., Gustchina A., Laco G.S., Wlodawer A., Elder J.H., and Kent S.B. Virology 224 1 (1996) 268-275
92. Shimojima M., Miyazawa T., Ikeda Y., McMonagle E.L., and Haining H. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303 (2004) 1192-1195
93. Shinazi R.F., Larder B.A., and Mellors J.W. Mutations in retroviral genes associated with drug resistance. Int. Antiviral News 5 (1993) 129-142
94. Silva A.M., Cachau R.E., Sham H.L., and Erickson J.W. J. Mol. Biol. 255 2 (1996) 321-346
95. Slee D.H., Laslo K.L., Elder J.H., Ollmann I.R., Gustchina A., Kervinen K., Zdanov A., Wlodawer A., and Wong C.H. J. Am. Chem. Soc. 117 (1995) 11867-11878
96. Sodora D.L., Shpaer E.G., Kitchell B.E., Dow S.W., and Hoover E.A. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol. 68 (1994) 2230-2238
97. Sodora D.L., Courcelle J., Brojatsch J., Berson A., and Wang Y.C. Analysis of a feline immunodeficiency virus provirus reveals patterns of gene sequence conservation distinct from human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 11 (1995) 531-533
98. Sparger E.E., Luciw P.A., Elder J.H., Yamamoto J.K., and Lowenstine L.J. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS 3 (1989) S43-S49
99. Sparger E.E., Shacklett B.L., Renshaw-Gegg L., Barry P.A., and Pedersen N.C. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187 (1992) 165-177
100. Steagall W.K., Robek M.D., Perry S.T., Fuller F.J., and Payne S.L. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology 210 (1995) 302-313
101. Swain A.L., Miller M.M., Green J., Rich D.H., Schneider J., Kent S.B., and Wlodawer A. Proc. Natl. Acad. Sci. U.S.A. 87 22 (1990) 8805-8809
102. Swanstrom R., and Erona J. Pharmacol. Ther. 86 2 (2000) 145-170
103. Swanstrom R., and Wills J. Synthesis, assembly, and processing of viral proteins. In: Coffin J., and Hughes S. (Eds). Retroviruses (1997), Cold Spring Harbor Laboratory Press, NY 263-334
104. Talbott R.L., Sparger E.E., Lovelace K.M., Fitch W.M., and Pedersen N.C. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5743-5747
105. Threadgill D.S., Steagall W.K., Flaherty M.T., Fuller F.J., and Perry S.T. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J. Virol. 67 (1993) 2592-2600
106. Tomasselli A.G., and Heinrikson R.L. Methods Enzymol. 241 (1994) 279-301
107. Toyosaki T., Miyazawa T., Furuya T., Tomonaga K., and Shin Y.S. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection. Arch. Virol. 131 (1993) 335-347
108. Tozser J., Gustchina A., Weber I.T., Blaha I., Wondrak E.M., and Oroszlan S. FEBS Lett. 279 2 (1991) 356-360
109. Tozser J., Weber I.T., Gustchina A., Blaha I., Copeland T.D., Louis J.M., and Oroszlan S. Biochemistry 31 20 (1992) 4793-4800
110. Tozser J., Bagossi P., Weber I.T., Louis J.M., Copeland T.D., and Oroszlan S. J. Biol. Chem. 272 27 (1997) 16807-16814
111. Vacca J.P. Drug Discov. 2 7 (1997)
112. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., and Kikonyogo A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7724-7729
113. Vogt V. Curr. Top. Microbiol. Immunol. 214 (1996) 95-131
114. Waters A.K., de Parseval A.P., Lerner D.L., Neil J.C., and Thompson F.J. Influence of ORF2 on host cell tropism of feline immunodeficiency virus. Virology 215 (1996) 10-16
115. Weber I.T., Miller M., Jaskolski M., Leis J., Skalka A.M., and Wlodawer A. Science 243 4893 (1989) 928-931
116. Wiegers K., Rutter G., Kottler H., Tessmer U., Hohenberg H., and Krausslich H.G. J. Virol. 72 4 (1998) 2846-2854
117. + lymphocyte subset. Immunology 78 (1993) 1-6
118. Willett B.J., Adema K., Heveker N., Brelot A., Picard L., Alizon M., Turner J.D., Hoxie J.A., Peiper S., Neil J.C., and Hosie M.J. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J. Virol. 72 (1998) 6475-6481
119. Wlodawer A., Gustchina A., Reshetnikova L., Lubkowski J., Zdanov A., Hui K.Y., Angleton E.L., Farmerie W.G., Goodenow M.M., and Bhatt D. Nat. Struct. Biol. 2 6 (1995) 480-488
120. Woo J.C., Dean G.A., Pedersen N.C., and Moore P.F. Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats. J. Virol. 71 (1997) 8632-8641
121. Xiang S.H., Farzan M., Si Z., Madani N., Wang L., Rosenberg E., Robinson J., and Sodroski J. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J. Virol. 79 (2005) 6068-6077
122. Yamamoto J.K., Sparger E., Ho E.W., Andersen P.R., O'Connor T.P., Mandell C.P., Lowenstine L., Munn R., and Pedersen N.C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49 (1988) 1246-1258
123. Young B., Johnson S., Bahktiari M., Shugarts D., Young R.K., Allen M., Ramey II R.R., and Kuritzkes D.R. J. Infect. Dis. 178 5 (1998) 1497-1501
124. Zhang Y.M., Imamichi H., Imamichi T., Lane H.C., Falloon J., Vasudevachari M.B., and Salzman N.P. J. Virol. 71 9 (1997) 6662-6670
125. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., and Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 (2003) 94-98